scispace - formally typeset
T

Timothy J. Whelan

Researcher at McMaster University

Publications -  307
Citations -  41521

Timothy J. Whelan is an academic researcher from McMaster University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 79, co-authored 292 publications receiving 35977 citations. Previous affiliations of Timothy J. Whelan include Baylor College of Medicine & Cancer Care Ontario.

Papers
More filters
Journal ArticleDOI

Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango)

TL;DR: This paper attempts to provide greater conceptual clarity about shared treatment decision-making, identify some key characteristics of this model, and discuss measurement issues.
Journal ArticleDOI

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

TL;DR: In this paper, the authors conducted a meta-analysis of individual patient data for 10,801 women in 17 randomised trials of radiotherapy versus no radiotherapy after breast-conserving surgery, 8337 of whom had pathologically confirmed node-negative (pN0) or node-positive (nN+) disease.
Journal ArticleDOI

Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model.

TL;DR: This revised framework provides a dynamic view of treatment decision-making by recognizing that the approach adopted at the outset of a medical encounter may change as the interaction evolves and has practical applications for clinical practice, research and medical education.
Journal ArticleDOI

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

TL;DR: After mastectomy and axillary dissection, radiotherapy reduced both recurrence and breast cancer mortality in the women with one to three positive lymph nodes in these trials even when systemic therapy was given.